Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KALEEM GILL

Allopathic & Osteopathic Physicians Family Medicine

NPI
1629012117
CMS profile
300046
Location
OREGON, OH

General Payments · PY2018–2024

$5,322.30

  • Reported across 386 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$281.54

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $281.54 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $200.36 11
PFIZER INC. $52.25 3
Astellas Pharma US Inc $14.54 1
Lilly USA, LLC $14.39 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,561.88 129
PY2019 $1,338.51 107
PY2020 $794.13 53
PY2021 $886.87 57
PY2022 $359.27 19
PY2023 $100.10 5
PY2024 $281.54 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.79 03/05/2024 Food and Beverage Undisputed 01/23/2026 1103798124 CMS
ABBVIE INC. $33.59 03/08/2024 Food and Beverage Undisputed 01/23/2026 1103798126 CMS
ABBVIE INC. $15.26 04/11/2024 Food and Beverage Undisputed 01/23/2026 1103798128 CMS
ABBVIE INC. $18.35 04/23/2024 Food and Beverage Undisputed 01/23/2026 1103798130 CMS
ABBVIE INC. $28.19 07/02/2024 Food and Beverage Undisputed 01/23/2026 1103798132 CMS
ABBVIE INC. $15.91 08/14/2024 Food and Beverage Undisputed 01/23/2026 1103798134 CMS
ABBVIE INC. $13.26 08/22/2024 Food and Beverage Undisputed 01/23/2026 1103798136 CMS
ABBVIE INC. $31.87 08/27/2024 Food and Beverage Undisputed 01/23/2026 1103798138 CMS
ABBVIE INC. $12.72 09/04/2024 Food and Beverage Undisputed 01/23/2026 1103798140 CMS
ABBVIE INC. $7.56 10/16/2024 Food and Beverage Undisputed 01/23/2026 1103798142 CMS
ABBVIE INC. $2.86 10/31/2024 Food and Beverage Undisputed 01/23/2026 1103798144 CMS
Astellas Pharma US Inc $14.54 02/27/2024 Food and Beverage Undisputed 01/23/2026 1139319386 CMS
Lilly USA, LLC $14.39 05/15/2024 Food and Beverage Undisputed 01/23/2026 1135114884 CMS
PFIZER INC. $13.95 02/06/2024 Food and Beverage Undisputed 01/23/2026 1131182327 CMS
PFIZER INC. $17.18 03/11/2024 Food and Beverage Undisputed 01/23/2026 1131252616 CMS
PFIZER INC. $21.12 04/03/2024 Food and Beverage Undisputed 01/23/2026 1131398486 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.